MedPath

BIPAP Vision Versus OPTIFLOW System Comparison in Acute Respiratory Failure After Cardio Thoracic Surgery

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Interventions
Device: Non invasive ventilation
Device: Non invasive ventilation (VNI)
Registration Number
NCT01458444
Lead Sponsor
Centre Chirurgical Marie Lannelongue
Brief Summary

The OPTIFLOW ™ use is becoming more common in acute respiratory failure cases, but its place in relation to VNI (Bi-PAP mode) is not yet defined. OPTIFLOW ™ vs the VNI comparison of the use, in the immediate postoperative period, should lead to define the role of each technique and lead to a optimal rationalization of patients management with acute respiratory failure after surgery.

Detailed Description

Main objective: to determine, if the initiation of OPTIFLOW™ system immediate after cardio/ thoracic surgery with acute respiratory failure or immediate after post extubation in patients at risk, is not less than the start a VNI per BIPAP Vision ®system. In terms of reintubation rates, refusal to continue the technique, or switch to another technique proposed.

Secondary objectives:

* To assess changes in the sensation of dyspnea

* To analyze the skin tolerance and the comfort in this population

* To analyze the evolution of hemodynamic and respiratory parameters

* To compare the number of bronchoscopy performed during the patient's stay in intensive care unit

* Assess the number of postoperative pneumonia and antibiotic consumption

* To determine whether the initiation of any treatment changes in the immediate postoperative length of stay in intensive care and comprehensive.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
830
Inclusion Criteria
  • Patients after cardiac/thoracic surgery with acute respiratory failure defined by the presence of the following criteria:

    • report PaO2/FiO2 <300
    • Respiratory rate> 25 for at least 2 hours
    • Getting involved accessory respiratory muscles
    • paradoxical breathing Or
  • In immediate after extubation, the patient will be eligible if present in the withdrawal test:

    • SaO2 <90% in 12 L of O2 during a trial of spontaneous ventilation tube on
    • PaO2 <10 kPa at a FiO2 ≥ 50% during a VS trial + pressure support
    • The presence of a risk factor: Obesity (BMI> 30), FEVG <40%, Failed extubation prior, stridor
Exclusion Criteria
  • Previous history of SAS
  • Patient tracheotomy
  • Comas non hypercapnic
  • bradypnea
  • Cardiac arrest
  • Gastric Surgery recent
  • Restlessness, lack of cooperation
  • Nausea, vomiting
  • Hemodynamic instability

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OPTIFLOWNon invasive ventilationOPTIFLOW system
BIPAPNon invasive ventilation (VNI)Non invasive ventilation (VNI) by BIPAP® vision
Primary Outcome Measures
NameTimeMethod
Failure of the ventilation systemOne week

Failure defined by reintubation rate, refusal to continue the technique, or switch to an another technique proposed breakdown

Secondary Outcome Measures
NameTimeMethod
number of postoperative pneumonia and antibiotic useone week
Skin tolerance and comfortOne week
Sensation of dyspneaone week
number of bronchoscopy performed during the patient's stay in Intensive Care Unitone week
Evolution of hemodynamic and respiratory parametersone week
length of stay in intensive careone week

Trial Locations

Locations (1)

Centre Chirurgical MarieLannelongue

🇫🇷

Le Plessis Robinson, Ile de France, France

© Copyright 2025. All Rights Reserved by MedPath